DeutschNewstral
Article
Mmarketwatch.com on 2019-03-01 18:09
Cannabis stocks mixed as investors parse FDA’s latest comments on CBD regulation
Related news
[Audio] Podcast: Non-binding Guidance: FDA’s Regulation of Products Containing CBDjdsupra.com- FDA’s Congressional Report Confirms Slow But Steady Progress on CBD Regulationjdsupra.com
- Is the tail wagging the dog? Large retailers’ embrace of CBD health products may force the FDA’s handjdsupra.com
Regulation needed for CBD boomArkansas Online- FDA balks at CBD regulationArkansas Online
- AStock indexes waver as investors parse Fed chief's commentsapnewsarchive.com
FDA’s Warning On CBD: Cannabis Stocks Drop, Companies ObjectForbes- Transforming Cosmetics Regulation: FDA’s Mandatory Compliance Shift for Safer Beautyjdsupra.com
- What to Know About FDA’s Recent Statements on CBDjdsupra.com
CBD Industry: FDA’s Vague Warning Confuses Consumers Even Moreobserver.com- DEA Moves CBD Drugs to Schedule V; Follows FDA’s Leadjdsupra.com
- The FDA’s Recent Warning Letters and Consumer Update on CBDjdsupra.com
- Five highlights from FDA’s new AI device regulation Action Planjdsupra.com
- Updates in the FDA’s Regulation of Digital Health Technologiesjdsupra.com
- MCannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limbomarketwatch.com
- FDA and Outgoing Commissioner Scott Gottlieb Open Up About Cannabis and CBD Regulationjdsupra.com
- How the CBD Industry Is Reacting to Increased Calls for FDA Regulationobserver.com
- Part III: Stakeholder Comments on FDA’s Interchangeability Guidance for Biosimilarsjdsupra.com
- FDA Regulation of CBD is TBDjdsupra.com